Exogenous contrast agent improves sensitivity of gradient-echo functional magnetic resonance imaging at 9.4 T

Magnetic Resonance in Medicine

Volumn 52, Issue 6, 2004, Pages 1272-1281

  Mandeville, Joseph B ^a,b   Jenkins, Bruce G ^a,b   Chen, Yin Ching I ^a,b   Choi, Ji Kyung ^a,b   Kim, Young R ^a,b   Belen, Deniz ^b   Liu, Christina ^a,b   Kosofsky, Barry E ^a,b   Marota, John J A ^a,b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

BOLD; Brain; CBV; MRI

Indexed keywords

BLOOD; BRAIN; BRAIN MAPPING; IRON OXIDES; MAGNETIC RESONANCE IMAGING; MAMMALS;

BLOOD OXYGEN LEVEL DEPENDENTS; BOLD; CEREBRAL BLOOD VOLUME(CBV); FUNCTIONAL BRAIN IMAGING; FUNCTIONAL MAGNETIC RESONANCE IMAGING; FUNCTIONAL SENSITIVITIES; MAGNETIC FIELD STRENGTHS; SUSCEPTIBILITY ARTIFACTS;

MAGNETIC FIELDS;

COCAINE; CONTRAST MEDIUM; IRON OXIDE; METHYLPHENIDATE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD OXYGEN LEVEL DEPENDENT MECHANISM; BRAIN CIRCULATION; BRAIN FUNCTION; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; MAGNETIC FIELD; MALE; MATHEMATICAL ANALYSIS; NEUROIMAGING; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; OXYGEN BLOOD LEVEL; RAT; SENSITIVITY ANALYSIS; SENSITIVITY AND SPECIFICITY; SIGNAL PROCESSING;

EID: 10044227472     PISSN: 07403194     EISSN: None     Source Type: Journal    
DOI: 10.1002/mrm.20278     Document Type: Article

References (27)

1. Dijkhuizen RM, Ren J, Mandeville JB, Wu O, Ozdag FM, Moskowitz MA, Rosen BR, Finklestein SP. Functional magnetic resonance imaging of reorganization in rat brain after stroke. Proc Natl Acad Sci USA 2001;98:12766-12771.
2. Abo M, Chen Z, Lai LJ, Reese T, Bjelke B. Functional recovery after brain lesion-contralateral neuromodulation: an fMRI study. Neuroreport 2001;12:1543-1547.
3. Dijkhuizen RM, Singhal AB, Mandeville JB, Wu O, Halpern EF, Finklestein SP, Rosen BR, Lo EH. Correlation between brain reorganization, ischemic damage, and neurologic status after transient focal cerebral ischemia in rats: a functional magnetic resonance imaging study. J Neurosci 2003;23:510-517.
4. Mandeville JB, Jenkins BG, Kosofsky BE, Moskowitz MA, Rosen BR, Marota JJA. Regional sensitivity and coupling of BOLD and CBV changes during stimulation of rat brain. Magn Reson Med 2001;45:443-447.
5. Chen YI, Mandeville JB, Nguyen TV, Talele A, Cavagna F, Jenkins BG. Improved mapping of pharmacologically induced neuronal activation using the IRON technique with superparamagnetic iron blood pool agents. J Magn Reson Imaging 2001;14:517-524.
6. Ugurbil K. High-field magnetic resonance. In: Toga AW, Mazziotta JC, editors. Brain Mapping: The Methods. 2nd ed. San Diego: Academic Press; 2002. p 291-313.
7. Gati JS, Menon RS, Ugurbil K, Rutt BK. Experimental determination of the BOLD field strength dependence in vessels and tissue. Magn Reson Med 1997;38:296-302.
8. Mandeville JB, Marota JJA, Kosofsky BE, Keltner JR, Weissleder R, Rosen BR, Weisskoff RM. Dynamic functional imaging of relative cerebral blood volume during rat forepaw stimulation. Magn Reson Med 1998;39:615-624.
9. Marota JJA, Mandeville JB, Weisskoff RM, Moskowitz MA, Rosen BR, Kosofsky BE. Cocaine activation discriminates dopamergic projections by temporal response: an fMRI study in rat. NeuroImage 2000;11:13-23.
10. Nguyen TV, Brownell AL, Iris Chen YC, Livni E, Coyle JT, Rosen BR, Cavagna F, Jenkins BG. Detection of the effects of dopamine receptor supersensitivity using pharmacological MRI and correlations with PET. Synapse 2000;36:57-65.
11. Reese T, Bjelke B, Porszasz R, Baumann D, Bochelen D, Sauter A, Rudin M. Regional brain activation by bicuculline visualized by functional magnetic resonance imaging. Time-resolved assessment of bicuculline-induced changes in local cerebral blood volume using an intravascular contrast agent. NMR Biomed 2000;13:43-49.
12. Kennan RP, Scanley BE, Innis RB, Gore JC. Physiological basis for BOLD MR signal changes due to neuronal stimulation: separation of blood volume and magnetic susceptibility effects. Magn Reson Med 1998;40:840-846.
13. Vanduffel W, Fize D, Mandeville JB, Nelissen K, Van Hecke P, Rosen BR, Tootell RBH, Orban GA. Visual motion processing investigated using contrast-enhanced fMRI in awake behaving monkeys. Neuron 2001;32:565-577.
14. Leite FP, Tsao D, Vanduffel W, Fize D, Sasaki Y, Wald LL, Dale AM, Kwong KK, Orban GA, Rosen BR, Tootell RB, Mandeville JB. Repeated fMRI using iron oxide contrast agent in awake, behaving macaques at 3 Tesla. Neuroimage 2002;16:283-294.
15. Mandeville JB, Marota JJA. Vascular filters of functional MRI: spatial localization using BOLD and CBV contrast. Magn Reson Med 1999;42:591-598.
16. Mandeville JB, Marota JJA, Ayata C, Moskowitz MA, Weisskoff RM, Rosen BR. An MRI measurement of the temporal evolution of relative CMRO2 during rat forepaw stimulation. Magn Reson Med 1999;42:944-951.
17. Hoge RD, Atkinson J, Gill B, Crelier GR, Marrett S, Pike GB. Linear coupling between cerebral blood flow and oxygen consumption in activated human cortex. Proc Natl Acad Sci USA 1999;96:9403-9408.
18. Raichle ME, Grubb RL, Gado MH, Eichling JO, Ter-Pogossian MM. Correlation between regional cerebral blood flow and oxidative metabolism. In vivo studies in man. Arch Neurol 1976;33:523-526.
19. Yacoub E, Shmuel A, Pfeuffer J, Van De Moortele PF, Adriany G, Andersen P, Vaughan JT, Merkle H, Ugurbil K, Hu X. Imaging brain function in humans at 7 Tesla. Magn Reson Med 2001;45:588-594.
20. Davis TL, Kwong KK, Weisskoff RM, Rosen BR. Calibrated functional MRI: Mapping the dynamics of oxidative metabolism. Proc Natl Acad Sci USA 1998;95:1834-1839.
21. Hoge RD, Atkinson J, Gill B, Crelier GR, Marrett S, Pike GB. Investigation of BOLD signal dependence on cerebral blood flow and oxygen consumption: the deoxyhemoglobin dilution model. Magn Reson Med 1999;42:849-863.
22. Kim SG, Rostrup E, Larsson HB, Ogawa S, Paulson OB. Determination of relative CMRO2 from CBF and BOLD changes: significant increase of oxygen consumption rate during visual stimulation. Magn Reson Med 1999;41:1152-1161.
23. Boxerman JL, Hamberg LM, Rosen BR, Weisskoff RM. MR contrast due to intravascular magnetic susceptibility perturbations. Magn Reson Med 1995;34:555-566.
24. Weissleder R, Elizondo G, Wittenberg K. Ultrasmall superparamagnetic iron oxide. Characterization of a new class of contrast agents for MR imaging. Radiologyogy 1990;175:489-493.
25. Zhao F, Wang P, Harel N, Nagoaka T, Kim S. Contrast agent-enhanced functional magnetic resonance imaging at 4.7T and 9.4T. 2003; Toronto, Ontario, p 1770.
26. Lee SP, Silva AC, Ugurbil K, Kim SG. Diffusion-weighted spin-echo fMRI at 9.4 T: microvascular/tissue contribution to BOLD signal changes. Magn Reson Med 1999;42:919-928.
27. Weisskoff RM, Zuo CS, Boxerman JL, Rosen BR. Microscopic susceptibility variation and transverse relaxation: theory and experiment. Magn Reson Med 1994;31:601-610.